| Product Code: ETC200137 | Publication Date: May 2022 | Updated Date: Jul 2026 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Ravi Bhandari | No. of Pages: 60 | No. of Figures: 40 | No. of Tables: 7 |
The Thailand Nuclear Medicine Radioisotopes Market was estimated at USD 241 Million in 2025 and is projected to reach USD 277 Million by 2032, growing at a CAGR of 2.0% from 2026 to 2032. This growth trajectory is fueled by a rising demand for accurate diagnostic tools and the increasing prevalence of chronic diseases, compelling hospitals and medical facilities to integrate advanced radioisotope technologies into their operations.
This graph highlights how the Thailand Nuclear Medicine Radioisotopes Market has steadily grown over the years, supported by major growth factors.

The table below presents the year‑wise growth rates along with the key drivers influencing the market
| Year | Growth Rate | Major Drivers |
| 2021 | -3.3% | decrease in healthcare investments |
| 2022 | 2.2% | growing adoption of diagnostics |
| 2023 | 3.1% | expansion of healthcare infrastructure |
| 2024 | 2.5% | increased public health funding |
| 2025 | 3.7% | rising demand for imaging |
| 2026 | 3.0% | increased domestic production output |
| 2027 | 2.2% | growth in preventive healthcare |
| 2028 | 2.6% | advancements in technology applications |
| 2029 | 2.8% | strengthening partnerships with hospitals |
| 2030 | 3.4% | increased regulatory support initiatives |
| 2031 | 3.4% | increased pharmaceutical industry usage |
| 2032 | 2.9% | growing awareness of benefits |
Note: Market size estimations and growth projections presented in this report are based on 6Wresearch's proprietary forecasting methodology, utilizing the latest available industry data, government publications, and primary research inputs.
The primary force shaping the Thailand Nuclear Medicine Radioisotopes Market is the growing adoption of nuclear medicine in hospitals and healthcare settings. As more healthcare providers seek innovative solutions for medical diagnostics and treatment, the reliance on radioisotopes has become increasingly pronounced.
Currently, the market is characterized by the frequent use of isotopes such as technetium-99m (Tc-99m) and fluorine-18 (F-18), which are crucial for various diagnostic imaging procedures. While the market remains relatively small compared to regional counterparts, the increasing interest from foreign suppliers is gradually improving the landscape.
Despite its growth potential, the Thailand Nuclear Medicine Radioisotopes Market is constrained by a complex regulatory environment that governs the production and usage of radioactive substances. Safety concerns surrounding radioactive materials necessitate stringent compliance measures, which can deter new suppliers and innovations. Furthermore, the need for specialized infrastructure to handle these isotopes complicates access for hospitals and healthcare providers, thereby limiting market potential.
Several current and emerging trends are shaping the demand for nuclear medicine radioisotopes in Thailand. The ongoing evolution of diagnostic technologies, particularly in PET and SPECT imaging, showcases a growing integration of advanced isotopes. Additionally, there is an increasing focus on personalized medicine, which necessitates tailored radioisotope applications for effective patient treatment. These trends indicate a shift toward more sophisticated approaches in both diagnostics and therapeutics.
Significant growth and investment opportunities exist within the Thailand Nuclear Medicine Radioisotopes Market. The rising number of healthcare facilities adopting advanced diagnostic tools presents a ripe environment for suppliers to introduce innovative isotopes and technologies. Furthermore, partnerships with international vendors can enhance local capabilities, expand product offerings, and improve accessibility to essential medical radioisotopes, ultimately benefiting patient care.
The Thai government has shown commitment to advancing healthcare through various initiatives aimed at enhancing nuclear medicine capabilities. Public spending on healthcare infrastructure and research grants for innovative medical technologies are being prioritized. Moreover, regulatory frameworks are being evaluated to streamline the approval processes for new radioisotopes and ensure safety standards, thereby encouraging investment and research in this crucial area of medicine.
Looking ahead to 2026-2032, the Thailand Nuclear Medicine Radioisotopes Market is poised for gradual expansion, driven by increasing healthcare demand and the continuous evolution of diagnostic techniques. As more hospitals adopt innovative technologies, the market will likely witness an uptick in both local and imported radioisotopes. Efforts to overcome regulatory challenges and enhance infrastructure will play a crucial role in determining the pace of this growth, ultimately shaping the future of nuclear medicine in the country.
Recent developments in the Thailand Nuclear Medicine Radioisotopes Market indicate a focus on collaboration between local suppliers and international manufacturers. There has been increased investment in research and development of novel isotopes to meet the rising demand for advanced imaging solutions. Additionally, efforts to improve the distribution network for radioisotopes are gaining traction, facilitating better access for medical facilities across the country.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Thailand Nuclear Medicine Radioisotopes Market Overview |
3.1 Thailand Country Macro Economic Indicators |
3.2 Thailand Nuclear Medicine Radioisotopes Market Revenues & Volume, 2022 & 2032F |
3.3 Thailand Nuclear Medicine Radioisotopes Market - Industry Life Cycle |
3.4 Thailand Nuclear Medicine Radioisotopes Market - Porter's Five Forces |
3.5 Thailand Nuclear Medicine Radioisotopes Market Revenues & Volume Share, By Types, 2022 & 2032F |
3.6 Thailand Nuclear Medicine Radioisotopes Market Revenues & Volume Share, By Application, 2022 & 2032F |
4 Thailand Nuclear Medicine Radioisotopes Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of cancer and other chronic diseases in Thailand |
4.2.2 Growing investments in healthcare infrastructure and technology |
4.2.3 Rising awareness about the benefits of nuclear medicine for accurate diagnosis and treatment |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for nuclear medicine radioisotopes |
4.3.2 Limited availability of skilled professionals for handling nuclear medicine procedures |
4.3.3 High initial setup costs and ongoing maintenance expenses |
5 Thailand Nuclear Medicine Radioisotopes Market Trends |
6 Thailand Nuclear Medicine Radioisotopes Market, By Types |
6.1 Thailand Nuclear Medicine Radioisotopes Market, By Types |
6.1.1 Overview and Analysis |
6.1.2 Thailand Nuclear Medicine Radioisotopes Market Revenues & Volume, By Types, 2022-2032F |
6.1.3 Thailand Nuclear Medicine Radioisotopes Market Revenues & Volume, By Technetium-99m (Tc-99m), 2022-2032F |
6.1.4 Thailand Nuclear Medicine Radioisotopes Market Revenues & Volume, By Thallium-201 (Tl-201), 2022-2032F |
6.1.5 Thailand Nuclear Medicine Radioisotopes Market Revenues & Volume, By Iodine (I-123), 2022-2032F |
6.1.6 Thailand Nuclear Medicine Radioisotopes Market Revenues & Volume, By Fluorine-18, 2022-2032F |
6.1.7 Thailand Nuclear Medicine Radioisotopes Market Revenues & Volume, By Rubidium-82 (Rb-82), 2022-2032F |
6.1.8 Thailand Nuclear Medicine Radioisotopes Market Revenues & Volume, By Iodine-131 (I-131), 2022-2032F |
6.1.9 Thailand Nuclear Medicine Radioisotopes Market Revenues & Volume, By Others, 2022-2032F |
6.1.10 Thailand Nuclear Medicine Radioisotopes Market Revenues & Volume, By Others, 2022-2032F |
6.2 Thailand Nuclear Medicine Radioisotopes Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 Thailand Nuclear Medicine Radioisotopes Market Revenues & Volume, By Oncology, 2022-2032F |
6.2.3 Thailand Nuclear Medicine Radioisotopes Market Revenues & Volume, By Cardiology, 2022-2032F |
6.2.4 Thailand Nuclear Medicine Radioisotopes Market Revenues & Volume, By Thyroid, 2022-2032F |
6.2.5 Thailand Nuclear Medicine Radioisotopes Market Revenues & Volume, By Neurology, 2022-2032F |
6.2.6 Thailand Nuclear Medicine Radioisotopes Market Revenues & Volume, By Others, 2022-2032F |
7 Thailand Nuclear Medicine Radioisotopes Market Import-Export Trade Statistics |
7.1 Thailand Nuclear Medicine Radioisotopes Market Export to Major Countries |
7.2 Thailand Nuclear Medicine Radioisotopes Market Imports from Major Countries |
8 Thailand Nuclear Medicine Radioisotopes Market Key Performance Indicators |
8.1 Number of new cancer cases diagnosed annually in Thailand |
8.2 Investments in healthcare infrastructure and technology in the country |
8.3 Percentage increase in the utilization of nuclear medicine procedures in healthcare institutions |
9 Thailand Nuclear Medicine Radioisotopes Market - Opportunity Assessment |
9.1 Thailand Nuclear Medicine Radioisotopes Market Opportunity Assessment, By Types, 2022 & 2032F |
9.2 Thailand Nuclear Medicine Radioisotopes Market Opportunity Assessment, By Application, 2022 & 2032F |
10 Thailand Nuclear Medicine Radioisotopes Market - Competitive Landscape |
10.1 Thailand Nuclear Medicine Radioisotopes Market Revenue Share, By Companies, 2025 |
10.2 Thailand Nuclear Medicine Radioisotopes Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here